Cardiology News

NEW YORK--(BUSINESS WIRE)--ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter in ambulatory surgery centers (ASCs) across the United States. The agreement is designed to help physician-led ASCs gain earlier access to next-generation technology for treatment of cardiac arrhythmias in the ASC setting. Pulsed field ablation (PFA) is emerging as one of the most important advances in t...

BOSTON--(BUSINESS WIRE)--Form Health, the national leader in science-based obesity and cardiometabolic care, today announced it has joined Eli Lilly and Company's new Lilly Employer Connect platform, helping employers expand access to obesity management medications through flexible benefit design and more predictable pricing. Through Lilly Employer Connect, employers can work with independent program administrators like Form to design programs that expand access to obesity treatment while addre...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2025 Results...

PITTSBURGH--(BUSINESS WIRE)--RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the New England Journal of Medicine has published full results of its phase 3 TETON-2 study evaluating the use of nebulized Tyvaso for the treatment of IPF. The publication is available online at NEJM.org. The study met its primary efficacy endpoint, with nebulized Tyvaso demonstrating statistically significant improvement in abso...

SAN FRANCISCO--(BUSINESS WIRE)--Biome Analytics today announced the launch of two groundbreaking cardiovascular administrator productivity tools: Biome Strategy Board™ and Biome Presentation Builder™. These purpose-built solutions eliminate manual reporting, streamline initiative tracking, and bring real-time accountability to cardiovascular service lines. Healthcare administrators are operating at capacity. Hospitals are operating at capacity. The burden of manual reporting continues to grow....

LIESTAL, Switzerland & TOKYO--(BUSINESS WIRE)--Curatis Holding AG (SIX: CURN) and Neupharma Co., Ltd. (“Neupharma”), a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology disorders, today announce an exclusive license and development agreement for corticorelin (C-PTBE-01) in Japan. Under the terms of the agreement, Neupharma will receive exclusive rights to develop and commercialize corticorelin for the treatment of peritumoral brain edema (PTBE) in...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home...

DALLAS--(BUSINESS WIRE)--Verily Life Sciences and Samsung Electronics America today announced a collaboration that will bring together Samsung’s Galaxy Watch 8 with Verily’s precision health platform, Pre, to provide an integrated solution for generating evidence and monitoring real-world populations. This joint offering aims to accelerate research for life sciences and government customers by combining advanced health analytics with consumer-grade wearable data. Through this collaboration, Ver...

SANTA CLARA--(BUSINESS WIRE)--HeartBeam to Attend Investor and Industry Conferences in March...